AstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2023

  1. Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 9, pp. 2691-2702

2022

  1. Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series

    Pharmaceutics, Vol. 14, Núm. 5

2021

  1. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 166, pp. 175-181

2018

  1. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  2. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 127, pp. 204-212